Community-acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials

  • Genne D
  • Kaiser L
  • Kinge T
 et al. 
  • 3

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

In order to determine the causes of treatment failure in
community-acquired pneumonia (CAP) clinical trials, a MEDLINE search for
all CAP studies published between 1990 and 1997 was performed.
Prospective, randomized studies comparing the efficacy of two or more
antibiotics in CAP were selected. Treatment failure was defined as
persistent fever, deterioration of patient's condition, or a change in
the prescribed antibiotic regimen. In 16% of the cases included in the
clinical trials, the treatment of CAP is unsuccessful. A significant
number of identified failure cases were owing to antibiotic
side-effects. Resistant pathogens are an unusual cause of failure
whatever the antibiotic used.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • D Genne

  • L Kaiser

  • T N Kinge

  • D Lew

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free